GR3032245T3 - Medicaments - Google Patents

Medicaments

Info

Publication number
GR3032245T3
GR3032245T3 GR990403333T GR990403333T GR3032245T3 GR 3032245 T3 GR3032245 T3 GR 3032245T3 GR 990403333 T GR990403333 T GR 990403333T GR 990403333 T GR990403333 T GR 990403333T GR 3032245 T3 GR3032245 T3 GR 3032245T3
Authority
GR
Greece
Prior art keywords
medicaments
Prior art date
Application number
GR990403333T
Other languages
English (en)
Inventor
Li Li-Bovet
Keith Arthur Johnson
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of GR3032245T3 publication Critical patent/GR3032245T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GR990403333T 1994-09-28 1999-12-22 Medicaments GR3032245T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (1)

Publication Number Publication Date
GR3032245T3 true GR3032245T3 (en) 2000-04-27

Family

ID=10762008

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403333T GR3032245T3 (en) 1994-09-28 1999-12-22 Medicaments

Country Status (32)

Country Link
US (1) US5849265A (el)
EP (1) EP0783302B1 (el)
JP (1) JPH10506887A (el)
KR (1) KR100375469B1 (el)
CN (1) CN1084614C (el)
AP (1) AP742A (el)
AT (1) ATE187063T1 (el)
AU (1) AU707922B2 (el)
BG (1) BG62839B1 (el)
BR (1) BR9509108A (el)
CZ (1) CZ286356B6 (el)
DE (1) DE69513671T2 (el)
DK (1) DK0783302T3 (el)
EE (1) EE03380B1 (el)
ES (1) ES2140706T3 (el)
FI (1) FI971279A0 (el)
GB (1) GB9419536D0 (el)
GE (1) GEP20002140B (el)
GR (1) GR3032245T3 (el)
HU (1) HU221856B1 (el)
IS (1) IS1991B (el)
MD (1) MD1900C2 (el)
MX (1) MX9702149A (el)
NO (1) NO313658B1 (el)
NZ (1) NZ292995A (el)
OA (1) OA10603A (el)
PL (1) PL181453B1 (el)
RO (1) RO118564B1 (el)
RU (1) RU2157188C2 (el)
SK (1) SK281519B6 (el)
UA (1) UA47412C2 (el)
WO (1) WO1996009816A1 (el)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
PT1169019E (pt) * 1999-04-14 2003-07-31 Glaxo Group Ltd Formulacao farmaceutica em aerossol
US6406745B1 (en) * 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
SI1775305T1 (sl) * 2000-08-05 2015-01-30 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
WO2002024623A2 (en) 2000-09-22 2002-03-28 Glaxo Group Limited Novel alkanoic acid derivatives
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SI1383786T1 (sl) * 2001-04-30 2009-02-28 Glaxo Group Ltd Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa
JP2005500290A (ja) * 2001-06-12 2005-01-06 グラクソ　グループ　リミテッド 抗炎症性の、１７β−カルボチオアートアンドロスタン誘導体である１７α複素環エステル
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds
EP1486203B1 (en) * 2001-08-03 2007-09-19 Glaxo Group Limited Surfactant compounds and uses thereof
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
WO2003068722A1 (en) 2002-02-13 2003-08-21 Glaxo Group Limited Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8198354B2 (en) 2003-08-11 2012-06-12 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
JP5053635B2 (ja) 2003-08-29 2012-10-17 グラクソ グループ リミテッド 医療用定量噴霧式吸入器及びそれに関連する方法
US7030255B2 (en) * 2004-03-09 2006-04-18 Lyondell Chemical Technology, L.P. Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor
EP1949891A1 (en) 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
ES2317306T3 (es) * 2004-10-12 2009-04-16 Generics (Uk) Limited Procedimiento para la preparacion de formulaciones en aerosol en suspension, en el que las particulas se forman por precipitacion dentro de un frasco de aerosol.
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
ES2060184T3 (es) * 1989-06-22 1994-11-16 Atta Moleculas anfifilicas conteniendo fluor y fosforo con propiedades tensoactivas.
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69109284T2 (de) * 1990-03-23 1995-08-24 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe.
WO1992000062A1 (en) * 1990-06-27 1992-01-09 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations

Also Published As

Publication number Publication date
CN1084614C (zh) 2002-05-15
JPH10506887A (ja) 1998-07-07
MD1900C2 (ro) 2002-12-31
DE69513671T2 (de) 2000-04-06
US5849265A (en) 1998-12-15
AP9700951A0 (en) 1997-04-30
SK281519B6 (sk) 2001-04-09
EE03380B1 (et) 2001-04-16
AU3532195A (en) 1996-04-19
HU221856B1 (hu) 2003-02-28
AU707922B2 (en) 1999-07-22
MX9702149A (es) 1998-04-30
ATE187063T1 (de) 1999-12-15
AP742A (en) 1999-04-26
CZ93697A3 (en) 1997-08-13
UA47412C2 (uk) 2002-07-15
RO118564B1 (ro) 2003-07-30
PL181453B1 (pl) 2001-07-31
EE9700061A (et) 1997-08-15
FI971279A (fi) 1997-03-26
EP0783302A1 (en) 1997-07-16
KR970705981A (ko) 1997-11-03
IS1991B (is) 2005-02-15
PL319342A1 (en) 1997-08-04
OA10603A (en) 2002-08-30
FI971279A0 (fi) 1997-03-26
KR100375469B1 (ko) 2003-10-17
CN1168630A (zh) 1997-12-24
NO971422D0 (no) 1997-03-25
NO313658B1 (no) 2002-11-11
BG101347A (en) 1997-12-30
WO1996009816A1 (en) 1996-04-04
DE69513671D1 (de) 2000-01-05
BR9509108A (pt) 1998-07-14
BG62839B1 (bg) 2000-09-29
CZ286356B6 (cs) 2000-03-15
RU2157188C2 (ru) 2000-10-10
GB9419536D0 (en) 1994-11-16
HUT77377A (hu) 1998-04-28
EP0783302B1 (en) 1999-12-01
NZ292995A (en) 1998-10-28
SK39397A3 (en) 1997-10-08
MD970134A (en) 1999-02-28
DK0783302T3 (da) 2000-05-29
NO971422L (no) 1997-05-23
MD1900B2 (en) 2002-04-30
IS4438A (is) 1997-03-10
GEP20002140B (en) 2000-06-25
ES2140706T3 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
GR3032245T3 (en) Medicaments
GB9606805D0 (en) Medicaments
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
GB9611947D0 (en) Medicaments
GB9618974D0 (en) Medicaments
GB9605293D0 (en) Medicaments
GB9418530D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9416365D0 (en) Medicaments
GB9611167D0 (en) Medicaments
GB9613096D0 (en) Medicaments
GB9424013D0 (en) Medicaments
EP0790829A4 (en) DRUG
GB9420699D0 (en) Medicaments
GB9420704D0 (en) Medicaments
GB9414896D0 (en) Medicaments
GB9414191D0 (en) Medicaments
GB9411606D0 (en) Medicaments
GB9411605D0 (en) Medicaments
GB9416158D0 (en) Medicaments
GB9410621D0 (en) Medicaments
GB9406715D0 (en) Medicaments
GB9425759D0 (en) Medicaments